Sponsor

Aardvark Therapeutics, Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Aardvark Therapeutics, Inc. appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861 · lead sponsor · 2024-12-20
TERMINATED
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034 · lead sponsor · 2024-07-23
TERMINATED
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434 · lead sponsor · 2022-05-27
COMPLETED
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847 · lead sponsor · 2022-03-01
COMPLETED
Study to Evaluate ARD-101 in Adults With ObesityNCT05121441 · lead sponsor · 2021-11-15
COMPLETED

Sponsor roles

lead sponsor5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.